|
WO2011088573A1
|
|
Set of probes for the detection and typing of 46 human papillomavirus mucosal types
|
|
CA2760392A1
|
|
Influenza viral peptides and fusion protein for immunization, methods and uses thereof
|
|
WO2010060208A1
|
|
Peptide adjuvants
|
|
CA2725596A1
|
|
Method of reducing motility in bacteria by overexpression of a gene of oi-1 genomic island
|
|
WO2009124378A1
|
|
Chimeric anti-measles antibody
|
|
WO2009111865A1
|
|
Reagents and methods for detecting influenza virus proteins
|
|
WO2009043155A2
|
|
Distinct hiv-1 gag and env epitopes of hla alleles associated with differential susceptibility to hiv-1 infection
|
|
WO2008131554A1
|
|
Apparatus and process for immunomagnetic isolation of microorganisms
|
|
EP2102744A1
|
|
Method and apparatus for creating a configurable browser-based forms application
|
|
WO2008046227A1
|
|
Method and apparatus for software policy management
|
|
CA2592366A1
|
|
Recombinant foot and mouth disease vaccine
|
|
CA2527445A1
|
|
Ether nitrile co-polymers containing sulfonic acid groups for pem application
|
|
US2006021454A1
|
|
Buoyancy-corrected gravimetric analysis system
|
|
WO2005054469A1
|
|
Anti-sars monoclonal antibodies
|
|
WO2004092420A1
|
|
Method and kit for molecular identification of smallpox
|
|
CA2463827A1
|
|
Methods and compositions for controlled release of bioactive compounds
|
|
AU2003257323A1
|
|
Method and system for aggregating and disseminating time-sensitive information
|
|
CA2493142A1
|
|
Recombinant vesicular stomatitis virus vaccines for viral hemorrhagic fevers
|
|
US2003235110A1
|
|
Method and apparatus for reproducible dissolution testing of pharmaceutical products
|
|
CA2474139A1
|
|
Major virulence factor detection and verocytotoxin type 2 subtype from clinical e. coli isolates using a one-step multiplex pcr
|
